PRZO (PRZO) Stock Price & Analysis
PRZO (PRZO) fell 3.12% to USD 0.49 as of July 25, 2026 at 02:21 UTC, according to Nexqual real-time market data.
PRZO last closed at USD 0.51; the session ranged USD 0.49–0.52 on volume of 431,242 shares. Market capitalization is $12.73M, with a 52-week range of USD 0.45–1.98 (NCM). Source: Nexqual, July 25, 2026 at 02:21 UTC.
Key Statistics (as of July 25, 2026 at 02:21 UTC)
| Price | USD 0.49 |
|---|---|
| Change | ▼ 3.12% (down) |
| Previous Close | USD 0.51 |
| Open | USD 0.51 |
| Day Range | USD 0.49 – 0.52 |
| 52-Week Range | USD 0.45 – 1.98 |
| Volume | 431,242 shares |
| Market Cap | $12.73M |
| Exchange | NCM |
Technical Analysis (PRZO)
Nexqual's technical model rates PRZO "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 38.08 (neutral) |
| vs SMA50 | Below (USD 0.56) |
| MACD | -0.02 (negative) |
Analyst Ratings (PRZO)
Wall Street analysts rate PRZO "None", per Nexqual as of July 25, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|
Earnings (PRZO)
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financials & Fundamentals (PRZO)
| Total Revenue | $1.05M |
|---|---|
| Revenue Growth (YoY) | +6.00% |
| Gross Margin | +4.77% |
| Operating Margin | -565.59% |
| Profit Margin | +0.00% |
| ROE | -380.47% |
| Debt / Equity | 9.72 |
| Current Ratio | 3.64 |
| Total Cash | $4.16M |
| Total Debt | $306,684 |
| Free Cash Flow | $-3.26M |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financial Health Score (PRZO)
Nexqual rates PRZO's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 02:21 UTC.
| Growth | Solid — Revenue +6% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $4M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$6M |
| Efficiency | Critical — ROE -380%, ROA -85.4% |
Ownership (PRZO)
| Insider Ownership | +3.50% |
|---|---|
| Institutional Ownership | +5.20% |
| Shares Outstanding | 25.93M |
| Float | 23.82M |
| Short % of Float | +4.11% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Leadership (PRZO)
PRZO is led by Ariel Alon (age 53), Chief Executive Officer, per Nexqual as of July 25, 2026 at 02:21 UTC.
| Chief Executive Officer | Ariel Alon (age 53) |
|---|---|
| Chief Financial Officer | Regev Livne (age 44) |
| Vice President of Sales | Oren Aviram (age 52) |
Major Backers & Investors (PRZO)
Notable institutional backers of PRZO include Thompson, Siegel & Walmsley LLC, Empery Asset Management, LP, Xtx Topco Ltd, according to Nexqual as of July 25, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Thompson, Siegel & Walmsley LLC | 2.55% |
| Empery Asset Management, LP | 1.09% |
| Xtx Topco Ltd | 0.6% |
| UBS Group AG | 0.35% |
| Jane Street Group, LLC | 0.27% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HUBC | Hub Cyber Security Ltd. | USD 1.08 | ▼ 2.7% |
| SPRC | SciSparc Ltd. | USD 5.33 | ▲ 10.12% |
| VCIG | VCI Global Limited | USD 0.51 | ▼ 24.83% |
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.55 | ▼ 7.74% |
| KITT | Nauticus Robotics, Inc. | USD 0.77 | ▼ 5.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:21 UTC. This page is informational and not investment advice.